Loading
collectionsCollection
Prostate Cancer Foundation (PCF)
Michael Milken's prostate cancer foundation, which funded the science behind abiraterone, enzalutamide and PSMA therapy and runs a precision-oncology network in US veterans' hospitals.
Overview
Founded 1993 (as CaP CURE). PCF-funded research contributed to abiraterone, enzalutamide, radium-223, PSMA imaging and radioligands, and germline testing guidance; the PCF-VA network provides genomic testing and trials to veterans; the Young Investigator awards have trained a generation of researchers. Patient resources include the Prostate Cancer Patient Guide and a Black-community outreach programme; ZERO Prostate Cancer and Movember are major partner organisations for support and awareness.
URL
Holds
The largest philanthropic funder of prostate cancer research (>$1 billion), Challenge Awards and Young Investigator programme, the PCF-VA Precision Oncology Program, patient guides, and the annual Scientific Retreat.
Licence
Copyright PCF
Maintainer
PCF
Similar pages
- PersonHoward I. Scher
Shares Stand Up To Cancer, Abiraterone acetate, Enzalutamide, Androgen receptor.
- PersonRahul Aggarwal
Shares Lutetium-177 vipivotide tetraxetan, PSMA, PSMA PET, Androgen receptor.
- PersonMichael Hofman
Shares Movember, Lutetium-177 vipivotide tetraxetan, PSMA, PSMA PET.
- PersonMichael Milken
Shares Prostate Cancer Foundation, Abiraterone acetate, Enzalutamide, Prostate cancer.
- PersonCharles L. Sawyers
Shares Prostate Cancer Foundation, Stand Up To Cancer, Enzalutamide, Androgen receptor.
- PersonJohannes Czernin
Shares Lutetium-177 vipivotide tetraxetan, PSMA, PSMA PET, Prostate cancer.
- PersonLouise Emmett
Shares Lutetium-177 vipivotide tetraxetan, PSMA, PSMA PET, Prostate cancer.
- PersonMichael J. Morris
Shares Lutetium-177 vipivotide tetraxetan, PSMA, PSMA PET, Prostate cancer.
cancers
technologies
targets
drugs
ApprovedSmall-molecule CYP17A1 inhibitor
Abiraterone acetate · Zytiga (generic)
ApprovedSmall-molecule AR antagonist
Enzalutamide · Xtandi
ApprovedRadioligand therapy (beta)
Lutetium-177 vipivotide tetraxetan · Pluvicto